FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015327541> ?p ?o ?g. }

• W2015327541 endingPage "207" @default.
• W2015327541 startingPage "202" @default.
• W2015327541 abstract "The association between frailty and health status in patients with heart failure with preserved ejection fraction (HFpEF) is not well known.The authors examined the association between: 1) patient-reported frailty, measured by the Fried frailty phenotype, Kansas City Cardiomyopathy Questionnaire Physical Limitation Score (KCCQ-PLS), 6-minute walking distance (6MWD), and other baseline characteristics; 2) baseline frailty compared with KCCQ-PLS and 24-week 6MWD; 3) frailty and changes in KCCQ-PLS and 6MWD; and 4) vericiguat and frailty at 24 weeks.In a post hoc analysis, patients in the VITALITY-HFpEF (Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF) trial were categorized as not frail (0 symptoms), prefrail (1-2 symptoms), and frail (≥3 symptoms) according to patient-reported number of frailty symptoms. Correlations and linear regression models were used to examine the association between frailty and other measures, and between frailty and KCCQ-PLS at baseline with 24-week 6MWD.Among 739 patients, 27.3% were not frail, 37.6% were prefrail, and 35.0% were frail at baseline. Frail patients were older, more likely to be women, and less likely to be from Asia. Baseline KCCQ-PLS and 6MWD (mean ± SD) among not frail, prefrail, and frail patients was 68.2 ± 23.2, 61.7 ± 22.6, and 48.4 ± 23.8 and 328.5 ± 117.1 m, 310.8 ± 98.9 m, and 250.7 ± 104.3 m (P < 0.01 for both). After accounting for baseline 6MWD, frailty status at baseline, but not KCCQ-PLS, was significantly associated with 6MWD at 24 weeks. By 24 weeks, 47.5% of patients had no change in frailty, 45.5% had become less frail, and 7.0% had become more frail. Treatment with vericiguat did not alter frailty status at 24 weeks.Patient-reported frailty is modestly correlated with both the KCCQ-PLS and 6MWD but offers prognostic insight into 6MWD at 24 weeks. (Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF [VITALITY-HFpEF]; NCT03547583)" @default.
• W2015327541 created "2016-06-24" @default.
• W2015327541 creator A5005684677 @default.
• W2015327541 creator A5029166309 @default.
• W2015327541 creator A5061404285 @default.
• W2015327541 date "1979-05-01" @default.
• W2015327541 modified "2023-09-25" @default.
• W2015327541 title "High-performance liquid chromatographic determination of dihydralazine in humand plasma" @default.
• W2015327541 cites W1971423363 @default.
• W2015327541 cites W1974464177 @default.
• W2015327541 cites W1982676146 @default.
• W2015327541 cites W2016356465 @default.
• W2015327541 cites W2027721306 @default.
• W2015327541 cites W2416342251 @default.
• W2015327541 cites W4238897932 @default.
• W2015327541 doi "https://doi.org/10.1016/s0021-9673(01)80463-5" @default.
• W2015327541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/546874" @default.
• W2015327541 hasPublicationYear "1979" @default.
• W2015327541 type Work @default.
• W2015327541 sameAs 2015327541 @default.
• W2015327541 citedByCount "14" @default.
• W2015327541 countsByYear W20153275412022 @default.
• W2015327541 crossrefType "journal-article" @default.
• W2015327541 hasAuthorship W2015327541A5005684677 @default.
• W2015327541 hasAuthorship W2015327541A5029166309 @default.
• W2015327541 hasAuthorship W2015327541A5061404285 @default.
• W2015327541 hasConcept C126322002 @default.
• W2015327541 hasConcept C1862650 @default.
• W2015327541 hasConcept C2992886853 @default.
• W2015327541 hasConcept C67761136 @default.
• W2015327541 hasConcept C71924100 @default.
• W2015327541 hasConceptScore W2015327541C126322002 @default.
• W2015327541 hasConceptScore W2015327541C1862650 @default.
• W2015327541 hasConceptScore W2015327541C2992886853 @default.
• W2015327541 hasConceptScore W2015327541C67761136 @default.
• W2015327541 hasConceptScore W2015327541C71924100 @default.
• W2015327541 hasIssue "1" @default.
• W2015327541 hasLocation W20153275411 @default.
• W2015327541 hasLocation W20153275412 @default.
• W2015327541 hasOpenAccess W2015327541 @default.
• W2015327541 hasPrimaryLocation W20153275411 @default.
• W2015327541 hasRelatedWork W1948170731 @default.
• W2015327541 hasRelatedWork W1973035946 @default.
• W2015327541 hasRelatedWork W2087491399 @default.
• W2015327541 hasRelatedWork W2111390454 @default.
• W2015327541 hasRelatedWork W2132310570 @default.
• W2015327541 hasRelatedWork W2177703973 @default.
• W2015327541 hasRelatedWork W2512949579 @default.
• W2015327541 hasRelatedWork W2995377144 @default.
• W2015327541 hasRelatedWork W4383421632 @default.
• W2015327541 hasRelatedWork W2182025991 @default.
• W2015327541 hasVolume "173" @default.
• W2015327541 isParatext "false" @default.
• W2015327541 isRetracted "false" @default.
• W2015327541 magId "2015327541" @default.
• W2015327541 workType "article" @default.